Neurotech Pharmaceuticals, Inc. is a private biotech company located in Cumberland, RI and Needham, MA, within the realm of Greater Boston’s vast biotechnology landscape. Since our inception more than 20 years ago, our focus has been on developing and commercializing transformative therapies for chronic eye diseases. The core platform technology, Encapsulated Cell Therapy (ECT), is a first-in-class drug delivery platform designed to slow the progression of chronic eye diseases. Neurotech’s first commercial product, ENCELTOTM(revakinagene taroretcel-lwey), is approved in the United States for the treatment of adults with idiopathic Macular Telangiectasia Type 2 (MacTel). Encapsulated cell-based gene therapy is designed to provide long-term, sustained delivery of therapeutic proteins for the treatment of chronic eye diseases. We are seeking an experienced Director of Field Reimbursement, which is a field-based, customer-facing position focused on developing, securing and maintaining access for Neurotech’s product NT-501 after approval and launch within their assigned region. The Director of Field Reimbursement is the primary point of contact for the designated treatment centers. They will be responsible for implementation of site readiness strategy, which includes assessing procurement options at the site, operational efficiency, and capacity. This role will be required to have a strategic understanding of the healthcare system around patient access, payer policy, reimbursement, and distribution networks, state Medicaid programs, 340B, and Medicare. We are currently hiring for newly created areas - Mid Atlantic and Rocky Mountain. Please note, this role is not eligible for agency recruiting support. Additionally, Neurotech does not accept unsolicited résumés or candidate profiles. If a candidate submitted in this manner is hired, no placement fee will be paid.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Number of Employees
51-100 employees